Shaping the Future of Patent Law: The Amgen v. Sanofi Decision and Bite-Sized Monopolies
Patently O
MAY 18, 2023
.” In a unanimous opinion delivered by Justice Gorsuch, the Supreme Court has affirmed the Federal Circuit’s decision invalidating Amgen’s functionally claimed genus of monoclonal antibodies. The case in question is Amgen Inc. Sanofi , 22-157, — U.S. — (2023) ( 21-757_k5g1 ).
Let's personalize your content